Repurposing β-Lactams for the Treatment of <i>Mycobacterium kansasii</i> Infections: An In Vitro Study
<i>Mycobacterium kansasii</i> (<i>Mkn</i>) causes tuberculosis-like lung infection in both immunocompetent and immunocompromised patients. Current standard therapy against <i>Mkn</i> infection is lengthy and difficult to adhere to. Although β-lactams are the most...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/12/2/335 |